Sylvie Labrecque

Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically

Miranda Thomas, Ann Kalita, Sylvie Labrecque et al. · Molecular and Cellular Biology · 1999 · 700 citations

Genetics, Human Polymorphism, Molecular Biology +18

The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α

Suiyang Li, Sylvie Labrecque, Maria Cristina Gauzzi et al. · Oncogene · 1999 · 269 citations

Molecular Virology, Immunodeficiencies, Pathogenesis +12

Analysis of the anti-p53 antibody response in cancer patients.

Sylvie Labrecque, Noga Naor, David M. Thomson et al. · PubMed · 1993 · 136 citations

Mutant P53, Tumor Biology, Mutant P53s +13

p53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation

Héla Makni, Eduardo L. Franco, Jane Haruko Lima Kaiano et al. · International Journal of Cancer · 2000 · 97 citations

Polygenic Risk, Inter-laboratory Variation, Genetic Epidemiology +22

Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response

Anirban Ghosh, Sylvie Labrecque, Greg Matlashewski · Vaccine · 2001 · 66 citations

Vaccination, Dna Vaccination, Parasitic Protozoa +8